Mesa Laboratories (MLAB) Stock
Niche testing instrument maker for healthcare and industry. Here's the price, business snapshot, and what's worth knowing about Mesa Laboratories in October 2026.
Mesa Laboratories, Inc. (MLAB) is a small-cap company providing specialised instruments, consumables and related services used to test, monitor and validate equipment and environments across healthcare, life‑sciences and industrial settings. With a market capitalisation around $434M, it operates in niche segments where product reliability, regulatory compliance and recurring consumables can contribute to steady revenue streams. Investors should note the firm's exposure to cyclical capital spending, regulatory cycles and competition from larger instrument manufacturers. As a smaller company, Mesa can offer growth potential but also tends to show higher volatility and thinner trading liquidity than larger peers. Financial performance will depend on product adoption, service contracts and geographic diversification. This summary is for general educational purposes only, not personalised investment advice; values can rise and fall and past performance is not a guide to the future. Consider your risk tolerance and consult a qualified adviser before investing.
Mesa Laboratories (MLAB) Stock Forecast
Analyst price target, next 12 months
$127.50
-2.3% vs today's $130.45
Price range over the last 12 months
Close to its 12-month high
Analysts covering Mesa Laboratories have a consensus 12-month target of $127.50, below the current price of $130.45.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 28 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Mesa Laboratories' stock with a target price of $127.5, indicating potential growth.
Financial Health
Mesa Laboratories is performing well with strong revenue and profits, supported by healthy cash flow.
Dividend
MESA LABORATORIES INC has a low dividend yield of 0.5%, making it less attractive for dividend-seeking investors. If you invested $1000 you would be paid $5 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Niche instrument exposure
Specialised products and consumables can create recurring sales and pricing power, though demand can fluctuate with customer capital budgets.
Quality and compliance
Products used in regulated environments benefit from high reliability and certification, but regulatory shifts can materially affect demand and costs.
Small‑cap growth potential
A market cap around $434M offers potential upside if the company executes, balanced by higher volatility and lower liquidity than large caps.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
